Clinical Trial Results: The Efficacy and Safety of TLL018 in Moderate-to-severe Plaque Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 trial results for TLL018 in moderate-to-severe plaque psoriasis, reporting efficacy and safety data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• TLL018

Snippet

Sponsor: Hangzhou Highlightll Pharmaceutical Co., Ltd | Conditions: Plaque Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2026-07-21